Personal information

Emails & domains

Verified email domains

Activities

Collapse all

Works (9)

Considerable decline in prostate cancer mortality in Nordic countries after 2000

Acta Oncologica
2025-01-27 | Journal article
DOI: 10.2340/1651-226X.2025.41334
Contributors: Rune Kvåle; Giske Ursin; Christian Ekanger; Bjørn Møller
Source: check_circle
Crossref

Reply to M. Kamrava and F. Montorsi et al

Journal of Clinical Oncology
2024-12-10 | Journal article
DOI: 10.1200/JCO-24-01345
Contributors: Christian Ekanger; Svein Inge Helle; Rune Kvåle; Lars Reisæter; Karsten Gravdal; Alfred Honoré; Olav Dahl
Source: check_circle
Crossref

Salvage Reirradiation for Locally Recurrent Prostate Cancer: Results From a Prospective Study With 7.2 Years of Follow-Up

Journal of Clinical Oncology
2024-06-01 | Journal article
DOI: 10.1200/JCO.23.01391
Contributors: Christian Ekanger; Svein Inge Helle; Lars Reisæter; Liv Bolstad Hysing; Rune Kvåle; Alfred Honoré; Karsten Gravdal; Sara Pilskog; Olav Dahl
Source: check_circle
Crossref

Clinical iterative model development improves knowledge-based plan quality for high-risk prostate cancer with four integrated dose levels

Acta Oncologica
2021-02-01 | Journal article
DOI: 10.1080/0284186x.2020.1828619
Part of ISSN: 0284-186X
Part of ISSN: 1651-226X
Contributors: Johanna Austrheim Hundvin; Kristine Fjellanger; Helge Egil Seime Pettersen; Britt Nygaard; Kari Revheim; Turid Husevåg Sulen; Christian Ekanger; Liv Bolstad Hysing
Source: Self-asserted source
Christian Ekanger

Ten-Year Results From a Phase II Study on Image Guided, Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost in High-Risk Prostate Cancer

Advances in Radiation Oncology
2020-05 | Journal article
DOI: 10.1016/j.adro.2019.11.007
Contributors: Christian Ekanger; Svein Inge Helle; Daniel Heinrich; Dag Clement Johannessen; Ása Karlsdóttir; Yngve Nygård; Ole Johan Halvorsen; Lars Reisæter; Rune Kvåle; Liv Bolstad Hysing et al.
Source: check_circle
Crossref

Impact of positive surgical margins on secondary treatment, palliative radiotherapy and prostate cancer‐specific mortality. A population‐based study of 13 198 patients

The Prostate
2019-12 | Journal article
DOI: 10.1002/pros.23911
Part of ISSN: 0270-4137
Part of ISSN: 1097-0045
Contributors: Rune Kvåle; Tor Å. Myklebust; Sophie D. Fosså; Kirsti Aas; Christian Ekanger; Svein I. Helle; Alfred Honoré; Bjørn Møller
Source: Self-asserted source
Christian Ekanger

Statistical motion modelling for robust evaluation of clinically delivered accumulated dose distributions after curative radiotherapy of locally advanced prostate cancer

Radiotherapy and Oncology
2018-08 | Journal article
DOI: 10.1016/j.radonc.2018.06.004
Part of ISSN: 0167-8140
Contributors: Liv B. Hysing; Christian Ekanger; Ándras Zolnay; Svein Inge Helle; Mana Rasi; Ben J.M. Heijmen; Marcin Sikora; Matthias Söhn; Ludvig Paul Muren; Sara Thörnqvist
Source: Self-asserted source
Christian Ekanger

Risk of radiation-induced secondary rectal and bladder cancer following radiotherapy of prostate cancer

Acta Oncologica
2015-10-21 | Journal article
DOI: 10.3109/0284186x.2015.1061691
Part of ISSN: 0284-186X
Part of ISSN: 1651-226X
Contributors: Camilla H. Stokkevåg; Grete M. Engeseth; Liv B. Hysing; Kristian S. Ytre-Hauge; Christian Ekanger; Ludvig P. Muren
Source: Self-asserted source
Christian Ekanger

Prediction of rectum and bladder morbidity following radiotherapy of prostate cancer based on motion-inclusive dose distributions

Radiotherapy and Oncology
2013-05 | Journal article
DOI: 10.1016/j.radonc.2013.03.029
Part of ISSN: 0167-8140
Contributors: Maria Thor; Lise Bentzen; Liv B. Hysing; Christian Ekanger; Svein-Inge Helle; Ása Karlsdóttir; Ludvig Paul Muren
Source: Self-asserted source
Christian Ekanger
How many people are using ORCID?